Study to Evaluate SAGE-324 in Participants With Essential Tremor

NCT05173012 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Tremor

Interventions

DRUG: SAGE-324
DRUG: SAGE-324 Matched Placebo

Sponsor

Sage Therapeutics

Collaborators

[object Object]